Boothbay Fund Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Boothbay Fund Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-101,000	Closed	-$9.1M	–	1831
2024 Q4	$9.1M	Buy	+101,000	New	+$9.79M	0.22%	116
2024 Q2	–	Sell	-29,700	Closed	-$2.82M	–	1891
2024 Q1	$2.82M	Buy	+29,700	New	+$2.76M	0.05%	396
2023 Q4	–	Sell	-139,800	Closed	-$10.2M	–	2044
2023 Q3	$10.2M	Buy	+139,800	New	+$11.2M	0.24%	74
2023 Q1	–	Sell	-20,200	Closed	-$1.68M	–	2538
2022 Q4	$1.68M	Sell	20,200 -6,600	-25%	-$534K	0.04%	665
2022 Q3	$2.13M	Sell	26,800 -34,900	-57%	-$2.94M	0.05%	543
2022 Q2	$4.58M	Sell	61,700 -46,500	-43%	-$3.49M	0.12%	207
2022 Q1	$9.72M	Buy	108,200 +97,800	+940%	+$9.03M	0.23%	71
2021 Q4	$1.16M	Sell	10,400 -50,700	-83%	-$6.11M	0.03%	683
2021 Q3	$7.68M	Buy	+61,100	New	+$7.87M	0.21%	89

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Boothbay Fund Management's XBI Position: Q2 2026 in Review

Boothbay Fund Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 30% in Q2 2026, buying an estimated $364K and bringing the position to 11,616 shares worth $1.84M. The position accounts for 0.02% of the portfolio, ranked #767.

Boothbay Fund Management first reported a position in XBI in Q1 2017 and has held it in 9 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Boothbay Fund Management held 11,616 shares of State Street SPDR S&P Biotech ETF worth $1.84M as of Q2 2026.
Boothbay Fund Management bought 2,692 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $364K.
State Street SPDR S&P Biotech ETF made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #767 holding.
Boothbay Fund Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 9 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.